Solar Capital Ltd. Announces Quarter Ended June 30, 2016

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Solar Capital Ltd. Announces Quarter Ended June 30, 2016 Financial Results; Net Asset Value Increase of 2.0%; Declares Quarterly Distribution of $0.40 per Share for Q3, 2016

NEW YORK, NY--(Marketwired - Aug 2, 2016) - Solar Capital Ltd. ( NASDAQ : SLRC ) (the "Company" or "Solar Capital"), today reported net investment income of $19.5 million, or $0.46 per share, for the quarter ended June 30, 2016.

At June 30, 2016, net asset value (NAV) grew to $21.51 per share. The 2.0% increase in NAV from the prior quarter resulted from unrealized appreciation due to a combination of a positive mark-to-market technical impact on investment fair values and fundamental improvement of a few specific credits, as well as overearning the quarterly distribution. At the end of the second quarter, the investment portfolio, on a cost basis, remained over 99% performing. At June 30, the fair value of the Company's Comprehensive Investment Portfolio* was $1.72 billion, an 11% increase from the prior quarter.

Also on August 2, 2016, the Company's Board of Directors declared a third quarter distribution of $0.40 per share payable on October 4, 2016 to stockholders of record on September 22, 2016. The specific tax characteristics will be reported to stockholders on Form 1099 after the end of the calendar year.

HIGHLIGHTS:

At June 30, 2016:   Comprehensive Investment portfolio* fair value: $1.72 billion   Number of portfolio companies*: 100   Net assets: $908.8 million   Net asset value per share: $21.51

Portfolio Activity** for the Quarter Ended June 30, 2016:   Investments made during the quarter: $173.4 million   Investments prepaid and sold during the quarter: $37.2 million

Operating Results for the Quarter Ended June 30, 2016:   Net investment income: $19.5 million   Net realized and unrealized gain: $15.6 million   Net increase in net assets from operations: $35.2 million   Net investment income per share: $0.46

* The Comprehensive Investment Portfolio, including number of portfolio companies, is comprised of Solar Capital Ltd.'s investment portfolio, Crystal Financial's full portfolio, and the senior secured loans held by the Senior Secured Unitranche Loan Program ("SSLP") attributable to the Company (and excludes the fair value of the equity interests in Crystal Financial and the SSLP).

** Includes investment activity through the SSLP attributable to the Company.

"We're pleased to report meaningful growth in our net investment income, net asset value, and Comprehensive Portfolio during Q2," said Michael Gross, Chairman and CEO of Solar Capital Ltd. "Our approximately $136 million of net originations consisted predominantly of senior secured floating rate loans in SSLP and our life science business, including the acquisition of the $74 million par value life science loan portfolio. Importantly, the credit performance of our borrowers continues to be solid, with over 99% performing on a cost basis. While a portion of our Q2 net investment income growth is attributable to one-time events, we believe we've constructed a portfolio that should provide us with a solid foundation for continued growth that should enable us to exceed our current quarterly distribution on a recurring basis."

Conference Call and Webcast

The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Wednesday, August 3, 2016. All interested parties may participate in the conference call by dialing (877) 726-5936 approximately 5-10 minutes prior to the call, international callers should dial (530) 379-4671. Participants should reference Solar Capital Ltd. and the participant passcode of 30407967 when prompted. A telephone replay will be available until August 17, 2016 and can be accessed by dialing (855) 859-2056 and using the passcode 30407967. International callers should dial (404) 537-3406. This conference call will also be broadcast live over the Internet and can be accessed by all interested parties through Solar Capital's website, www.solarcapltd.com . To listen to the webcast, please go to the Company's website prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay of the webcast will be available soon after the call.

Portfolio and Investment Activity

Investment Activity

During the three months ended June 30, 2016, Solar Capital, including its ownership of SSLP, had gross originations of $173.4 million across 23 portfolio companies. Investments sold or prepaid during the quarter ended June 30, 2016 totaled approximately $37.2 million.

Portfolio Composition

At June 30, 2016, the weighted average yield on our income-producing investments, inclusive of our equity interests in Crystal Financial and SSLP, was 10.2%, measured at fair value, and 10.5%, measured at amortized cost. As of June 30, 2016, we continued to have only one issuer on non-accrual status, representing less than 0.6% of the cost of the investment portfolio.

Our Comprehensive Investment Portfolio composition at June 30, 2016 was as follows:

Comprehensive Portfolio Composition, measured at fair value: Amount ($mm) %
Senior secured loans - excluding Life Science $741.5 43.2%
Senior secured loans - Life Science $227.5 13.2%
Senior secured loans in SSLP, attributable to Solar Capital $117.1 6.8%
Senior secured loans in Crystal Financial $517.4 30.1%
Total Senior Secured Loans $1,603.5 93.3%
Unsecured Securities $75.3 4.4%
Equity and equity-like securities, excluding Crystal Financial and SSLP Membership Interests $39.2 2.3%
Total Comprehensive Investment Portfolio $1,718.0 100.0%
Floating Rate Investments as % of the Income-producing Comprehensive Portfolio $1,553.6 91.8%

The Comprehensive Portfolio is diversified across 100 unique issuers across 37 distinct industries and with an average exposure of $17.2 million or 1% per issuer.

Crystal Financial

At June 30, 2016, Crystal Financial's $517.4 million funded portfolio consisted of senior secured loans to 30 issuers with an average exposure of $17.2 million. All of the commitments at Crystal Financial are floating-rate, senior-secured loans. For the quarter ended June 30, 2016, Crystal Financial invested approximately $64.2 million and had investments repaid or sold of approximately $49.0 million. For the quarter ended June 30, 2016, Crystal distributed $7.9 million to Solar Capital, resulting in an annualized distribution yield, at cost, of approximately 11.5%, consistent with the prior quarter.

Senior Secured Unitranche Loan Program

As of June 30, 2016, the Company and Voya had contributed combined equity capital in the amount of $118.7 million to SSLP.

As of June 30, 2016, SSLP's $133.8 million portfolio consisted of floating rate senior secured loans to 7 different borrowers. During the quarter, SSLP originated $41.5 million in 4 portfolio companies. Investments repaid during the same period totaled $0.3 million, consisting of contractual amortization. At June 30, 2016, the weighted average yield of SSLP's portfolio was 7.6%, measured at fair value, and 7.6%, measured at cost.

On June 30, 2016, a wholly owned subsidiary of SSLP entered into a $200 million senior secured revolving credit facility (the "SSLP Facility"). The SSLP Facility is scheduled to mature on June 30, 2021 and generally bears interest at a rate of LIBOR plus 2.50%. There were no borrowings outstanding as of June 30, 2016.

Life Science Lending Platform

The fair value of the life science first lien senior secured portfolio was $227.5 million at June 30, 2016, consisting of first lien loans to 26 different borrowers with an average investment of $8.7 million. At June 30, 2016, the weighted average yield of the life science loan portfolio, excluding the impact of any exit/success fees and future warrant gains, was 11.7% measured at fair value and 11.8% measured at cost. During the second quarter of 2016, the life science lending platform originated $96.6 million of investments and had $9.6 million of repayments.

During the second quarter, Solar Capital completed the purchase of Capital One's Healthcare Life Science Finance portfolio which Capital One had acquired from GE Capital in 2015. The approximately $74.4 million par value portfolio of senior secured first lien loans acquired by the Company was comprised of 14 issuers with an average outstanding loan balance of $5.3 million. Many of the loans were underwritten by members of our team while they were employed by GE Capital. We expect a mid-teens IRR on the acquired portfolio. 

Results of Operations for the Quarter Ended June 30, 2016 compared to the Quarter Ended June 30, 2015.

Investment Income

For the fiscal quarters ended June 30, 2016 and 2015, gross investment income totaled $41.4 million and $28.0 million, respectively. The increase in gross investment income from 2015 to 2016 was primarily due to a larger income producing portfolio as well as prepayment fees.

Expenses

Net expenses totaled $21.8 million and $12.0 million, respectively, for the fiscal quarters ended June 30, 2016 and 2015. The increase in expenses from 2015 to 2016 was primarily due to higher management fees, performance-based incentive fees and interest expense on a larger income producing investment portfolio.

Net Investment Income

The Company's net investment income totaled $19.5 million and $16.0 million, or $0.46 and $0.38, per average share, respectively, for the fiscal quarters ended June 30, 2016 and 2015.

Net Realized and Unrealized Gain (Loss)

Net realized and unrealized gains (losses) for the fiscal quarters ended June 30, 2016 and 2015 totaled approximately $15.6 million and $1.3 million, respectively. The net realized and unrealized gain of $15.6 million for the quarter ended June 30, 2016 was primarily due to appreciation in the value of certain investments.

Net Increase in Net Assets Resulting From Operations

For the fiscal quarters ended June 30, 2016 and 2015, the Company had a net increase in net assets resulting from operations of $35.2 million and $17.3 million, respectively. For the same periods, earnings per average share were $0.83 and $0.41, respectively.

Liquidity and Capital Resources

As of June 30, 2016, the Company had a total of $142.1 million of unused borrowing capacity under the Company's credit facility, subject to borrowing base limits. Additionally, at June 30, 2016, SSLP had $200 million of unused borrowing capacity on the SSLP Facility, subject to borrowing base limits.

Portfolio and Asset Quality

The Company puts its largest emphasis on risk control and credit performance. On a quarterly basis, or more frequently if deemed necessary, the Company formally rates each portfolio investment on a scale of one to four, with 1 representing the least amount of risk.

As of June 30, 2016, the composition of our portfolio, on a risk ratings basis, was as follows:

Internal Investment Rating   Investments at Fair Value % of Total Portfolio
1   $167.1 11.3%
2   $1,227.6 82.8%
3   $85.6 5.8%
4   $2.4 0.2%

Financial Statements and Tables

   
SOLAR CAPITAL LTD.  
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES  
(in thousands, except share amounts)  
   
  June 30, 2016 (unaudited)     December 31, 2015  
Assets              
Investments at fair value:              
  Companies less than 5% owned (cost: $1,050,816 and $926,055, respectively) $ 1,030,543     $ 886,788  
  Companies 5% to 25% owned (cost: $8,511 and $8,511, respectively)   1,361       1,233  
  Companies more than 25% owned (cost: $428,556 and $410,142, respectively)   450,826       424,570  
               
    Total investments (cost: $1,487,883 and $1,344,708, respectively)   1,482,730       1,312,591  
Cash   1,522       2,587  
Cash equivalents (cost: $141,988 and $274,983, respectively)   141,988       274,983  
Receivable for investments sold   14,005       11,374  
Interest receivable   10,063       6,408  
Dividends receivable   9,425       8,487  
Prepaid expenses and other assets   1,143       874  
               
  Total assets $ 1,660,876     $ 1,617,304  
               
Liabilities              
Revolving credit facilities $ 347,900     $ 207,900  
Unsecured senior notes ($100,000 and $100,000 face amounts, respectively, reported net of unamortized debt issuance costs of $2,941 and $2,996, respectively   97,059       97,004  
Senior secured notes   75,000       75,000  
Term loan   50,000       50,000  
Distributions payable   16,899       16,986  
Payable for investments and cash equivalents purchased   147,189       274,983  
Management fee payable   7,179       6,523  
Performance-based incentive fee payable   5,877       1,408  
Administrative services expense payable   1,674       2,324  
Interest payable   1,917       1,665  
Other liabilities and accrued expenses   1,339       813  
               
  Total liabilities $ 752,033     $ 734,606  
               
               
               
Net Assets              
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 42,248,525 and 42,464,762 shares issued and outstanding, respectively $ 422     $ 425  
Paid-in capital in excess of par   990,586       993,991  
Distributions in excess of net investment income   (12,943 )     (15,592 )
Accumulated net realized loss   (64,069 )     (64,009 )
Net unrealized depreciation   (5,153 )     (32,117 )
               
  Total net assets $ 908,843     $ 882,698  
               
Net Asset Value Per Share $ 21.51     $ 20.79  
               
               
SOLAR CAPITAL LTD.  
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)  
(in thousands, except share amounts)  
   
           
  Three months ended  
  June 30, 2016     June 30, 2015  
INVESTMENT INCOME:              
Interest:              
  Companies less than 5% owned $ 30,702     $ 18,830  
  Companies more than 25% owned   477       683  
Dividends:              
  Companies less than 5% owned   --       2  
  Companies more than 25% owned   9,866       8,459  
Other income:              
  Companies less than 5% owned   299       --  
  Companies more than 25% owned   25       4  
               
    Total investment income   41,369       27,978  
               
EXPENSES:              
Management fees $ 7,179     $ 6,036  
Performance-based incentive fees   5,877       --  
Interest and other credit facility expenses   5,543       3,629  
Administrative services expense   1,481       1,560  
Other general and administrative expenses   1,756       762  
               
  Total expenses   21,836       11,987  
               
               
    Net investment income $ 19,533     $ 15,991  
               
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, CASH EQUIVALENTS AND FOREIGN CURRENCIES:              
Net realized gain (loss) on investments and cash equivalents:              
  Companies less than 5% owned $ 38     $ (452 )
  Companies 5% to 25% owned   (100 )     (350 )
  Companies more than 25% owned   --       20  
               
    Net realized loss on investments and cash equivalents   (62 )     (782 )
Net realized gain (loss) on foreign currencies   1       --  
               
    Net realized loss   (61 )     (782 )
               
Net change in unrealized gain (loss) on investments and cash equivalents   15,704       2,063  
Net change in unrealized gain (loss) on foreign currencies   (1 )     4  
               
    Net change in unrealized gain (loss)   15,703       2,067  
               
      Net realized and unrealized gain (loss) on investments, cash equivalents and foreign currencies   15,642       1,285  
               
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS $ 35,175     $ 17,276  
               
EARNINGS PER SHARE $ 0.83     $ 0.41  
               
               

About Solar Capital Ltd.

Solar Capital Ltd. is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. The Company invests primarily in leveraged, middle market companies in the form of senior secured loans, unitranche loans, mezzanine loans, and equity securities.

Forward-Looking Statements

Statements included herein may constitute "forward-looking statements," which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. Solar Capital Ltd. undertakes no duty to update any forward-looking statements made herein.

Contact Investor Relations (646) 308-8770

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 180

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 298

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 343

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 229

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading